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This report describes a patient with extensive pyoderma gangrenosum in whom there were co-existent 
lung abnormalities. The patient’s X-ray showed peripherally sited multiple pulmonary lesions bilaterally. 
A lung biopsy showed chronic non-specific inflammatory changes with neutrophil and lymphocyte 
infiltration which were similar to the skin lesions. This case was diagnosed as multiple aseptic nodules in 
pyoderma gangrenosum. The pulmonary infiltrative shadows were controlled only with prednisolone 
treatment. Steroid therapy is considered to be the first choice to control pulmonary lesions of this 
disease. 
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Introduction 
Pyoderma gangrenosum is a chronic inflammatory 
cutaneous disease of unknown aetiology. Although it 
is basically considered to be a dermatological disease, 
its clinical appearance seems to be systemic in some 
aspects. For example, pyoderma gangrenosum is 
often associated with chronic inflammatory bowel 
disease, rheumatoid arthritis, gammopathies or mul- 
tiple myeloma. However, few cases with pulmonary 
involvement have been reported. The present case 
report describes a case of pyoderma gangrenosum 
with multiple aseptic pulmonary lesions which 
responded to corticosteroid treatment. 
Case Report 
A 50-year-old male office worker was admitted to 
the authors’ dermatological ward in November 1993. 
He complained of painful skin ulcerations on both 
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legs (Plate 1). Histological examination showed 
inflammatory changes with neutrophil and lym- 
phocyte infiltration, without angitis or granuloma. 
These macroscopic and microscopic findings demon- 
strated typical features of pyoderma gangrenosum. 
Steroid treatment was started and the eruptions 
gradually improved. He was discharged in March 
1994 with a maintenance dose of prednisolone 
(7.5 mg day- ‘). 
Disease remission continued until September 1994, 
when he started to complain of cough and slight 
chest pain. Chest X-ray showed bilateral infiltrative 
shadows accompanied by pleural effusion and pleural 
thickening on the right side (Plate 2). He was 
treated with oral antibiotics but the shadows did not 
change, so he was referred to the authors’ department 
on 7 November 1994. 
The patient was afebrile. There was a dull area on 
percussion and breath sounds were slightly weak at 
the right basal area, but crackles were not audible. 
Laboratory findings revealed leukocytosis (white 
blood cells 13 200 mm - 3: 75% neutrophils, no 
eosinophilia), haemoglobin 13.4 g dl - ‘, platelet 
count 461000 mm-3, erythrocyte sedimentation rate 
30mmh-‘, C-reactive protein 2.1 mg dl ~ ‘, IgG 
2530mgdll’, IgA 418mgdll’, IgM 197mgdl-’ 
(normal range of IgG: 885-1822 mg dl- ‘, IgA: 
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PLATE 1. Ulceration of the leg is a typical manifes- 
tation of pyoderma gangrenosum. 
96-393 mg dl - ‘, IgM: 44-295 mg dl - ‘). Other bio- 
chemical blood tests were normal. Rheumatoid factor 
was negative and both cytoplasmic antineutrophil 
cytoplasmic autoantibody (C-ANCA) and peri- 
nuclear cytoplasmic antineutrophil cytoplasmic auto- 
antibody (P-ANCA) were negative. Tumour markers 
were negative. Repeated sputum cultures, including 
those for tuberculosis, were negative. Tomography 
showed bilateral peripherally located multiple nodu- 
lar lesions (Plate 3). A lung biopsy performed from 
the right middle lobe bronchus showed chronic non- 
specific inflammatory changes with neutrophil and 
lymphocyte infiltration which were similar to the skin 
lesions, but there was no evidence of bronchiolitis 
obliterans, granuloma, vasculitis or malignancy. 
Bronchial washing fluid culture was negative. Percu- 
taneous aspiration by thoracentisis was performed, 
and fluid cultures including anaerobic culture and 
culture for tuberculosis were negative. Cytologic 
examination of the lavage fluid showed no malig- 
nant cells, only neutrophils and lymphocytes. After 
PLATE 2. Chest X-ray on admission showed bi- 
lateral infiltrative shadows which accompanied with 
slight pleural effusion and thickening. 
PLATE 3. Chest computerized tomographic scan 
demonstrated bilateral peripherally located multiple 
nodular lesions next to the pleura. 
examination, antibiotic therapy with clindamycin 
(1200 mg day - ‘) and isepamicin (400 mg day - ‘) was 
given intravenously for 10 days, but there was no 
pulmonary improvement. This case was diagnosed as 
multiple, aseptic nodules in pyoderma gangrenosum. 
Oral prednisolone was increased to 40 mg day - i, and 
the infiltrative shadows rapidly decreased over a few 
weeks. The patient was discharged on 25 November 
1994 and prednisolone was tapered to 10 mg day- ‘. 
During the subsequent 10 months, no relapse has 
been recognized. 
Discussion 
Pulmonary involvement of pyoderma gangrenosum 
is uncommon and has been seldom reported (1). 
Previously reported histological findings of pulmo- 
nary lesions are similar to those of the present case 
(2-4). The lung abscesses were aseptic (24). In the 
other cases, pulmonary lesions showed a single uni- 
lateral opacity on chest X-ray. The present patient 
had an unusual form of pyoderma gangrenosum with 
multiple pulmonary involvement which has not been 
reported previously. 
Pyoderma gangrenosum is characterized by an 
aseptic inflammatory cutaneous disease of unknown 
aetiology. It is associated with basic immunological 
disorders like Crohn’s disease, ulcerative colitis, rheu- 
matoid arthritis, vasculitis, lymphomas, leukaemias, 
dysproteinemias or multiple myeloma (5). There may 
be auto-immune factors in the development of the 
disease process. The previous reported cases with 
pulmonary lesions also had basic diseases, ulcerative 
colitis and rheumatoid arthritis. This case showed 
increase of immunoglobulins, but there were no 
clinical complications of other immunological dis- 
orders (6). Sarcoidosis or vasculitis like Wegener’s 
granulomatosis (7) was ruled out by the clinical and 
histological findings. 
In this case, the response to steroid therapy was 
dramatic, as in previously reported cases. Steroid 
therapy is considered to be the first choice to control 
pulmonary lesions of pyoderma gangrenosum. 
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